利用深度生存模型来预测各种医院再入院的护理质量风险
Nhat Quang Tran1, Gautam Goel1, Nirmala Pudota2
1AI Center of Excellence, Deloitte & Touche LLP, New York, USA.
Scientific reports
|June 28, 2023
概括
高的住院再接收率带来了财务负担. 机器学习生存分析有效地预测了再接收风险,SparseDeepWeiSurv模型显示了评估医疗保健质量的最佳表现.
科学领域:
- 医疗信息学 医疗信息学
- 机器学习 机器学习
- 生存分析的分析.
背景情况:
- 在全球范围内,高的住院再接收率严重加重了医疗保健系统的负担.
- 再接收率是评估医疗保健提供者护理质量的关键指标.
- 预测再入院对于改善患者的治疗结果和降低医疗保健成本至关重要.
研究的目的:
- 评估基于机器学习的生存分析,以评估医院再入院治疗质量的风险.
- 探索先进的特征表示技术,以预测再接收风险.
- 确定最有效的生存模型来预测医院再入院.
主要方法:
- 将各种生存模型应用于医疗保健索赔数据集,包括患者人口统计和出院信息.
- 利用高级功能表示技术,如BioBERT和Node2Vec用于诊断代码.
- 采用基于深度学习的生存分析模型来预测再接收风险,独立于特定条件或固定再接收窗口.
主要成果:
- 该SparseDeepWeiSurv模型,使用韦布尔分布来计算回收时间,证明了优越的区分能力和校准.
- 对诊断代码的高级功能嵌入 (BioBERT,Node2Vec) 并没有提高模型性能.
- 模型性能因评估时间点而异,这表明需要适应性模型选择.
结论:
- 基于深度学习的生存分析是有效的估计医院再入院的护理质量风险.
- 选择生存模型可能需要依赖时间,以获得最佳的护理质量评估.
- 未来的研究应该考虑再接收风险预测的时间动态.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
Introduction To Survival Analysis
293
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
293
Actuarial Approach
99
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
99
Assumptions of Survival Analysis
160
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
160


